(Q66394811)
Statements
A Phase 1, Randomized, Double-blind, Placebo-controlled, Single Ascending Dose Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of GX-I7 in Healthy Volunteers (English)
0 references
11 July 2016
0 references
20 January 2017
0 references
30
0 references
19 year
0 references
45 year
0 references